Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare and digital health company focused on portable, semiconductor-based ultrasound technology and ultrasound software solutions. The Butterfly Network news feed on Stock Titan highlights company announcements that relate to its handheld ultrasound devices, Ultrasound-on-Chip™ semiconductor platform, enterprise software and AI initiatives.
Investors and healthcare professionals following BFLY news will see updates on financial results and guidance, such as quarterly earnings releases and preliminary revenue expectations furnished through press releases and 8-K filings. These items often include commentary on revenue growth, cash usage, chip development milestones and the progress of enterprise offerings like Compass™ and Compass AI™.
News coverage also features product and platform developments, including launches of new software capabilities such as Compass AI, announcements about AI-enabled clinical tools like Auto B-line Counter or a Gestational Age AI tool, and information about developer-focused initiatives like Butterfly Garden™ and the planned Beam Steering API. These stories provide insight into how Butterfly is expanding its imaging platform and exposing core capabilities to partners and developers.
Another recurring theme in Butterfly Network news is global health and clinical impact. Press releases describe programs in Sub-Saharan Africa involving handheld probes, training and AI tools for obstetric ultrasound, as well as clinical publications that examine how Butterfly’s devices and software can affect workflows, costs and provider economics in hospital systems.
In addition, the BFLY news stream includes capital markets and corporate updates, such as participation in healthcare investor conferences, executive appointments and SEC-reported events like the NYSE’s decision to delist Butterfly’s public warrants while leaving the common stock listing under BFLY unchanged. For readers tracking Butterfly Network, this page offers a consolidated view of operational, financial, technological and regulatory developments as they are publicly disclosed.
Kansas City University (KCU) is pioneering point-of-care ultrasound (POCUS) education by introducing a first-of-its-kind, hands-on POCUS elective in its 2024 curriculum. KCU is the first U.S. medical school to use Butterfly Network's AI-guided ScanLab™ application as the foundation of its POCUS curriculum. The program focuses on student scanning proficiency, ensuring graduates are prepared for residency and clinical settings.
The AI-powered ScanLab™ app provides real-time feedback, anatomical labeling, and grading, enabling students to learn independently. Nearly 300 students have enrolled in KCU's POCUS elective series, using personal Butterfly handheld ultrasound devices. This innovative approach addresses the gap in POCUS training in medical schools, setting a new standard for medical education in the 21st century.
Butterfly Network, Inc. (NYSE: BFLY) has published a case study highlighting the successful implementation of its point-of-care ultrasound (POCUS) devices and Compass™ workflow software at the University of Rochester Medical Center (URMC). The deployment resulted in a 116% increase in ultrasound charge capture across the health system. URMC has deployed 862 Butterfly devices across 64 departments and plans to scale to 2,500 devices by 2026.
Key achievements include:
- Nearly 50,000 scanning sessions completed since 2022
- 74% increase in scanning sessions in 2023
- 147% rise in studies uploaded from Butterfly devices
- 1,782% jump in images uploaded from non-Butterfly devices
These results have contributed to earlier diagnoses and improved patient outcomes while reducing emergency visits.
Butterfly Network (NYSE:BFLY) has been named one of 2024's Fierce 50 honorees by Fierce Life Sciences and Fierce Healthcare. This recognition highlights Butterfly's advancements in medical imaging through its portable, semiconductor-based ultrasound technology. Key achievements include:
1. The successful launch of the next-generation Butterfly iQ3™
2. Establishment of the Butterfly Garden™ program for ultrasound AI innovation
3. Creation of a chip-licensing program for partners to develop technologies Powered by Butterfly™
CEO Joseph DeVivo emphasized the company's mission to democratize medical imaging by improving access, affordability, and sustainability. The Fierce 50 recognition underscores Butterfly's role in driving digital revolution in the ultrasound industry.
Butterfly Network Inc. (NYSE: BFLY) has launched its third-generation handheld point-of-care ultrasound system, Butterfly iQ3™, in Europe. The device, built on advanced Ultrasound-on-Chip™ technology, offers improved image quality, new 3D imaging capabilities, and a smaller, lighter design. Key features include:
1. Unparalleled image quality with twice the processing power of its predecessor
2. Novel tools: iQ Slice™ and iQ Fan™ for advanced 3D imaging
3. Ergonomic design: 17% smaller probe face, 7% shorter probe, and 2.5x faster charging
4. CE marked and EU MDR certified
The Butterfly iQ3 is now available in 16 European countries, expanding the company's mission to democratize ultrasound technology.
Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld, whole-body ultrasound and intuitive software, has announced its participation in Lake Street Capital Markets' 8th Annual Best Ideas Growth Conference. The event is scheduled for September 12, 2024, in New York City.
Heather Getz, Chief Financial and Operations Officer at Butterfly Network, will be representing the company in one-on-one investor meetings during the conference. This participation provides an opportunity for Butterfly Network to showcase its innovative technology and growth potential to investors.
Interested parties can schedule meetings with Heather Getz through their Lake Street representatives, offering a chance for in-depth discussions about the company's future prospects and strategies.
Butterfly Network (NYSE: BFLY) has appointed Steve Cashman as Chief Business Officer, effective immediately. Cashman, a seasoned healthcare leader, joins the company following its successful launch of the third-generation Butterfly iQ3 and record revenue performance in H1 2024. He will oversee global sales, marketing, product, and corporate strategy as part of the Executive Management Team.
Cashman brings extensive health technology expertise and commercial leadership, having previously served as CEO of Caption Health and CCO at InTouch Health. His appointment follows Butterfly's announcement of its highest quarterly revenue in Q2, reaching $21.5 million, a 16% year-over-year growth. This achievement underscores the growing demand for Butterfly's innovative ultrasound technology and the effectiveness of its strategy.
Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld, whole-body ultrasound and intuitive software, has announced its participation in TD Cowen's 9th Annual FutureHealth Conference on September 10, 2024 in New York City. Nevada Sanchez, Co-Founder & Vice President of Core Technology at Butterfly Network, will be part of a panel discussion titled 'AI in the Healthcare Ecosystem' from 3:15 pm to 4:00 pm ET.
The panel will be an in-person event without virtual streaming options. Interested parties can contact their TD Cowen representative for more information or to schedule meetings with Butterfly Network management during the conference.
Avive Solutions, Inc., a manufacturer of innovative Automated External Defibrillators (AEDs) and software solutions, has appointed Katerina Miras as their Vice President of Marketing. Miras, with extensive experience in medtech, brings expertise in creating healthcare brands that accelerate commercial growth. She previously held leadership roles at Medivis and Butterfly Network (NYSE: BFLY), where she contributed to significant market share growth and brand recognition.
As VP of Marketing, Miras will focus on enhancing Avive's brand identity, driving awareness, and leading the company's marketing strategy in the AED and cardiac arrest response space. Her vision includes increasing the presence of Avive's AEDs in key markets and championing the company's mission to improve Sudden Cardiac Arrest outcomes through faster, more connected care.
Butterfly Network (NYSE: BFLY) reported its Q2 2024 financial results, highlighting record quarterly revenue of $21.5 million, representing 16% YoY growth. The company reduced its net loss by 45% and net cash used in operations by 62% YoY.
Key achievements include the launch of the iQ3 in Canada, expansion into Southeast Asia, and success with the medical school Campus Essentials program. Butterfly also made significant strides in AI and technology with new development partnerships.
Financial highlights include a gross profit of $12.6 million and operating expenses down by 29% YoY. The company improved its adjusted EBITDA guidance and regained compliance with NYSE listing standards.
Butterfly Network (NYSE: BFLY) has announced it will report its second quarter 2024 financial results on August 1, 2024, after market close. The company, known for its portable ultrasound technology, will host a conference call and webcast at 5:00 pm ET on the same day. Joseph DeVivo, President, CEO, and Chairman, along with Heather Getz, EVP and CFO, will lead the discussion on financial results and operational progress.
The call will be broadcast live via webcast on Butterfly's Investor Relations website. Interested parties can also dial in to listen. A replay of the call will be available until August 15, 2024. This announcement indicates Butterfly's commitment to transparency and shareholder communication, providing investors with an opportunity to gain insights into the company's performance and future outlook.
FAQ
What is the current stock price of Butterfly Network (BFLY)?
What is the market cap of Butterfly Network (BFLY)?
